Publications
Export 115 results:
Author Title Type [ Year
Filters: Author is Pedro Rosa-Neto [Clear All Filters]
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.. Brain. 144(11):3517-3528.
.
2021. Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(9):1592-1599.
.
2021. Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.. Mol Neurodegener. 16(1):28.
.
2021. Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views.. Curr Neurol Neurosci Rep. 21(10):52.
.
2021. Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [F]-FEOBV.. Parkinsonism Relat Disord. 91:162-166.
.
2021. Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease.. Neuroimage Clin. 31:102733.
.
2021. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease.. Alzheimers Res Ther. 13(1):69.
.
2021. Preclinical longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.. J Cereb Blood Flow Metab. :271678X211035625.
.
2021. Preliminary Evaluations of [C]Verubulin: Implications for Microtubule Imaging With PET.. Front Neurosci. 15:725873.
.
2021. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease.. Transl Psychiatry. 11(1):251.
.
2021. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(11):2048-2049.
.
2021. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.. Brain Commun. 3(3):fcab099.
.
2021. Soluble amyloid-beta isoforms predict downstream Alzheimer's disease pathology.. Cell Biosci. 11(1):204.
.
2021. Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset.. Neuroscience. 480:143-154.
.
2022. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid.. Clin Chem Lab Med. 60(2):207-219.
.
2022.